Equities

Visioneering Technologies Inc

VTI:ASX

Visioneering Technologies Inc

Actions
Health CareMedical Equipment and Services
  • Price (AUD)0.14
  • Today's Change0.00 / 0.00%
  • Shares traded71.00
  • 1 Year change-37.78%
  • Beta1.9438
Data delayed at least 20 minutes, as of Nov 15 2024 00:38 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments3.004.9611
Total Receivables, Net0.970.730.91
Total Inventory2.161.861.41
Prepaid expenses1.040.961.15
Other current assets, total------
Total current assets7.178.5014
Property, plant & equipment, net0.180.260.11
Goodwill, net------
Intangibles, net0.290.150.16
Long term investments------
Note receivable - long term------
Other long term assets0.010.210.20
Total assets7.659.1115
LIABILITIES
Accounts payable0.490.360.54
Accrued expenses1.260.981.25
Notes payable/short-term debt000
Current portion long-term debt/capital leases------
Other current liabilities, total00.060.33
Total current liabilities1.761.392.12
Total long term debt01.212.74
Total debt01.212.74
Deferred income tax------
Minority interest------
Other liabilities, total0.130.210.01
Total liabilities1.892.814.87
SHAREHOLDERS EQUITY
Common stock0.050.030.02
Additional paid-in capital989593
Retained earnings (accumulated deficit)(92)(89)(83)
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total------
Total equity5.766.2910
Total liabilities & shareholders' equity7.659.1115
Total common shares outstanding523325
Treasury shares - common primary issue----0
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.